

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Nusinersen is a groundbreaking medication that offers hope for people with spinal muscular atrophy (SMA), a genetic condition that affects muscle strength and movement. This treatment works by helping nerve cells produce more of a protein they need to function properly, which can slow down muscle weakness and even improve motor skills in some patients.
If you or a loved one has been diagnosed with SMA, you're likely feeling overwhelmed with questions about treatment options. Understanding how nusinersen works and what to expect can help you feel more prepared and confident as you navigate this journey with your healthcare team.
Nusinersen is an antisense oligonucleotide medication specifically designed to treat spinal muscular atrophy. It's the first FDA-approved treatment for this condition, representing a major breakthrough in SMA care since its approval in 2016.
The medication works at the genetic level by targeting the root cause of SMA. People with SMA have a defective gene that doesn't produce enough of a protein called SMN (survival motor neuron protein). Nusinersen helps the body make more of this crucial protein, which nerve cells need to stay healthy and function properly.
This treatment is given directly into the spinal fluid through a procedure called intrathecal injection. While this might sound intimidating, it's necessary because the medication needs to reach the spinal cord and brain where it can do its work most effectively.
Nusinersen is used to treat all types of spinal muscular atrophy, from the most severe infant forms to milder adult versions. SMA is a genetic condition that causes progressive muscle weakness and loss of movement because nerve cells in the spinal cord don't get the protein they need to survive.
The medication has shown remarkable results across different types of SMA. In infants with the most severe form, it can help with basic functions like swallowing, breathing, and even achieving motor milestones they might not have reached otherwise. For children and adults with milder forms, it can help maintain current abilities and sometimes even improve strength and function.
Your doctor will determine if nusinersen is right for your specific situation based on your type of SMA, current symptoms, and overall health. The treatment has been studied extensively and continues to show promise for people at various stages of the condition.
Nusinersen works by essentially giving your body's cells new instructions for making a vital protein. Think of it as providing a backup plan when the original genetic instructions aren't working properly.
People with SMA have a faulty SMN1 gene, but they also have a backup gene called SMN2. The problem is that SMN2 usually doesn't produce enough functional protein on its own. Nusinersen acts like a molecular editor, helping the SMN2 gene produce more of the full-length, working protein that nerve cells desperately need.
This is considered a targeted therapy because it addresses the specific genetic cause of SMA rather than just treating symptoms. While it's not a cure, it can significantly slow disease progression and, in many cases, help people maintain or even improve their motor function. The medication is quite potent and represents one of the most advanced genetic therapies available today.
Nusinersen is given as an injection directly into the spinal fluid, a procedure called intrathecal injection. This isn't something you can do at home – it requires a medical professional, typically a neurologist or other specialist experienced with this procedure.
The injection is usually done in a hospital or clinic setting. You'll lie on your side, and the doctor will use a thin needle to inject the medication into the space around your spinal cord, similar to how a spinal tap is performed. The procedure typically takes about 30 minutes, though you may need to stay for observation afterward.
Before the injection, you don't need to avoid food or water unless your doctor specifically instructs otherwise. Some people find it helpful to stay well-hydrated before the procedure. After the injection, you'll likely be asked to lie flat for a period of time to reduce the risk of headaches.
Your healthcare team will provide specific instructions based on your individual needs and medical history. Don't hesitate to ask questions about what to expect – they want you to feel as comfortable and prepared as possible.
Nusinersen is typically a long-term treatment that you'll continue indefinitely. The medication follows a specific schedule that starts with more frequent doses and then spreads out over time.
Initially, you'll receive four loading doses over about two months. The first three doses are given every 14 days, and the fourth dose comes 30 days after the third one. After these loading doses, you'll receive maintenance doses every four months for as long as you and your doctor decide the treatment is beneficial.
The decision to continue treatment depends on how well you're responding and whether you're experiencing any concerning side effects. Many people continue nusinersen for years because stopping the medication can lead to a return of disease progression. Your doctor will regularly assess your progress through physical exams, motor function tests, and discussions about your quality of life.
Some families worry about the long-term commitment, but remember that this treatment has shown sustained benefits for many people. Your medical team will work with you to make sure the treatment plan continues to make sense for your specific situation.
Most people tolerate nusinersen well, but like any medication, it can cause side effects. The good news is that serious side effects are relatively uncommon, and many people experience only mild, temporary symptoms.
The most common side effects are related to the injection procedure itself. These might include headache, back pain, or nausea, which typically resolve within a day or two. Some people also experience mild fever or fatigue after the injection, which is usually your body's normal response to the procedure.
Here are the more common side effects you might experience:
Most of these symptoms are manageable and tend to improve as your body gets used to the treatment schedule.
While less common, there are some more serious side effects that require immediate medical attention. These include severe headache that doesn't improve with rest or over-the-counter pain relievers, signs of infection like persistent fever or unusual weakness, or any severe allergic reactions.
Here are the rare but serious side effects to watch for:
Your healthcare team will monitor you carefully for these effects and teach you what signs to watch for at home. Remember, the benefits of nusinersen have been shown to outweigh the risks for most people with SMA.
Nusinersen is generally safe for most people with SMA, but there are some situations where your doctor might need to consider alternatives or take extra precautions. The decision always depends on your individual health profile and specific circumstances.
People with certain blood clotting disorders or those taking blood-thinning medications may need special monitoring or dose adjustments. This is because the injection procedure carries a small risk of bleeding, and your doctor wants to minimize any complications.
Your doctor will also carefully consider nusinersen if you have active infections, particularly around the spine or in your central nervous system. In these cases, they might want to treat the infection first before proceeding with nusinersen injections.
Here are some conditions that might require special consideration:
Even if you have one of these conditions, it doesn't automatically mean you can't receive nusinersen. Your doctor will weigh the potential benefits against the risks and may be able to modify the treatment plan to make it safer for you.
Nusinersen is marketed under the brand name Spinraza by Biogen, a biotechnology company that developed this groundbreaking treatment. You'll see both names used interchangeably in medical literature and when talking with your healthcare team.
Spinraza is the name you'll most commonly encounter when dealing with insurance companies, pharmacies, and treatment centers. This branded medication is currently the only FDA-approved version of nusinersen available, so there are no generic alternatives at this time.
The medication comes in single-use vials that contain exactly the right dose for injection. Your treatment center will order Spinraza specifically for your appointments, and it requires special handling and storage to maintain its effectiveness.
While nusinersen was the first approved treatment for SMA, the landscape of SMA therapy has expanded significantly. There are now other FDA-approved options that work through different mechanisms, giving families more choices than ever before.
Gene therapy with onasemnogene abeparvovec (Zolgensma) is another groundbreaking treatment that works by providing a functional copy of the SMN1 gene. Unlike nusinersen, this is typically given as a one-time intravenous infusion, though it's primarily used in very young children.
There's also risdiplam (Evrysdi), an oral medication that works similarly to nusinersen by helping the SMN2 gene produce more functional protein. This daily liquid medication can be taken at home, which some families find more convenient than regular injections.
Here are the main alternatives to consider:
Your doctor will help you understand which option might be best based on your age, type of SMA, current symptoms, and personal preferences. Some people even use combinations of these treatments under careful medical supervision.
Both nusinersen and risdiplam are effective treatments for SMA, but they each have unique advantages that might make one more suitable for your specific situation. There's no universal "better" choice – it really depends on your individual circumstances and preferences.
Nusinersen has been available longer and has more extensive long-term data showing sustained benefits over many years. It's been proven effective across all types of SMA and has helped many people maintain or improve their motor function. However, it requires regular injections into the spinal fluid every four months.
Risdiplam offers the convenience of daily oral dosing at home, which many families find less disruptive to their routine. It's also easier for people with spine abnormalities who might have difficulty with intrathecal injections. However, it's a newer medication with less long-term data available.
Here's how they compare on key factors:
Your neurologist will consider factors like your age, type of SMA, current function level, and personal preferences when helping you choose. Some people even switch between treatments if their circumstances change.
Is Nusinersen Safe for Pregnancy?
The safety of nusinersen during pregnancy hasn't been extensively studied, so this is definitely a conversation to have with your healthcare team if you're planning to become pregnant or already are. Your doctor will weigh the potential benefits of continuing treatment against any unknown risks.
Many women with SMA have successfully had healthy pregnancies, and some have continued nusinersen treatment during pregnancy under close medical supervision. The decision depends on your individual health, how well you're responding to treatment, and your overall pregnancy risk factors.
If you're of childbearing age, it's important to discuss family planning with your SMA care team well before you're ready to conceive. They can help you understand your options and develop a plan that keeps both you and your future baby as healthy as possible.
What Should I Do if I Accidentally Miss a Dose of Nusinersen?
If you miss a scheduled nusinersen injection, don't panic – this happens sometimes due to illness, scheduling conflicts, or other life circumstances. The most important thing is to reschedule your appointment as soon as possible and get back on track with your treatment schedule.
Contact your treatment center immediately to discuss rescheduling. They'll work with you to find the earliest available appointment and may adjust your future schedule slightly to maintain the proper intervals between doses. Missing one dose typically doesn't cause immediate problems, but you don't want to delay too long.
Your medical team understands that life happens, and they're experienced in helping patients manage scheduling challenges. They might also be able to provide guidance on whether any adjustments to your monitoring schedule are needed after a missed dose.
When Can I Stop Taking Nusinersen?
The decision to stop nusinersen is complex and should always be made in partnership with your healthcare team. Most people continue treatment long-term because stopping can lead to a return of disease progression, potentially undoing some of the benefits you've gained.
However, there are situations where stopping might be considered, such as if you're experiencing serious side effects that outweigh the benefits, if your condition has progressed significantly despite treatment, or if you're transitioning to a different therapy.
Your doctor will regularly assess how well nusinersen is working for you through physical exams, motor function tests, and quality of life discussions. These evaluations help determine whether continuing treatment makes sense for your specific situation.
If you're considering stopping treatment, have an open conversation with your care team about your concerns and goals. They can help you understand the potential consequences and explore whether there are ways to address any issues you're experiencing while continuing treatment.
How Long Does It Take to See Results from Nusinersen?
The timeline for seeing results from nusinersen varies significantly from person to person, and it's important to have realistic expectations about what changes might occur and when. Some people notice improvements within the first few months, while others may take longer to see meaningful changes.
In clinical trials, some participants showed improvements in motor function within 2-3 months of starting treatment, but more significant changes often took 6-12 months or longer. The type of improvements you might see depends on your age, type of SMA, and current level of function when you start treatment.
For infants with severe SMA, improvements might include better swallowing, increased alertness, or achieving motor milestones. For children and adults with milder forms, benefits might be more subtle, such as maintained strength, improved endurance, or slower progression of weakness.
Your healthcare team will use standardized assessments to track your progress objectively, but they'll also want to hear about changes you notice in daily activities and quality of life. Remember that stabilization of symptoms – not getting worse – is also a significant benefit of treatment.
Does Insurance Cover Nusinersen Treatment?
Most insurance plans, including Medicare and Medicaid, do cover nusinersen treatment, but the approval process can sometimes be complex. This is a high-cost medication, so insurance companies typically require prior authorization and documentation that the treatment is medically necessary.
Your healthcare team and treatment center usually have dedicated staff who specialize in working with insurance companies to secure coverage. They'll help gather the necessary documentation, submit prior authorization requests, and advocate for your treatment approval.
If you encounter insurance challenges, don't give up. There are often appeals processes available, and pharmaceutical companies sometimes offer patient assistance programs for people who meet certain criteria. Your treatment center can connect you with resources and support to help navigate these challenges.
Start the insurance approval process as early as possible, as it can take several weeks or longer to get everything sorted out. Keep detailed records of all communications with your insurance company, and don't hesitate to ask for help from your care team's insurance specialists.
Get clear medical guidance
on symptoms, medications, and lab reports.